Ainos Inc (AIMD)

Nov 25, 2024

Ainos, Inc. Reports Q3 Financial Results and Strategic Developments - TipRanks

Nov 25, 2024

Nov 15, 2024

AIMD Stock Hits 52-Week Low at $0.4 Amid Market Challenges - Investing.com India

Nov 15, 2024

Nov 14, 2024

AIMDAinos, Inc. Latest Stock News & Market Updates - StockTitan

Nov 14, 2024

Nov 13, 2024

Ainos (AIMD) Advances VELDONA Trial for Sjogren's: Key IRB Approval Secured, 28 Patents Added | AIMDW Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Ainos, Inc. (NASDAQ:AIMD) Sees Large Decline in Short Interest - Defense World

Nov 13, 2024

Nov 11, 2024

Ainos Advances Sjögren's Treatment: Key Trial for VELDONA® Gets IRB Green Light | AIMDW Stock News - StockTitan

Nov 11, 2024

Nov 09, 2024

Ainos Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.73 loss in 3Q 2023) - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Ainos reports unusual stock activity to regulators - Investing.com India

Nov 08, 2024

Nov 08, 2024

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities - WICZ

Nov 08, 2024

Nov 08, 2024

Ainos reports unusual stock activity to regulators By Investing.com - Investing.com UK

Nov 08, 2024

Nov 08, 2024

Ainos (AIMD) Alerts SEC to Suspicious Trading Activity, Demands Investigation | AIMDW Stock News - StockTitan

Nov 08, 2024

Nov 07, 2024

Ainos (OTCMKTS:AIMD) Stock Price Up 14.7% – Here’s Why - Defense World

Nov 07, 2024

Nov 06, 2024

Ainos Reports Third Quarter 2024 Financial Results - StockTitan

Nov 06, 2024

Nov 05, 2024

Behcet's syndrome Treatment Market 2034: Clinical Trials, EMA, - openPR

Nov 05, 2024

Oct 31, 2024

Ainos stock plunges to 52-week low of $0.45 amid steep annual decline - Investing.com

Oct 31, 2024

Oct 31, 2024

Analyzing CONMED (NYSE:CNMD) & Ainos (OTCMKTS:AIMD) - Defense World

Oct 31, 2024

Oct 29, 2024

Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 37.6% in October - Defense World

Oct 29, 2024

Oct 28, 2024

Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets - StockTitan

Oct 28, 2024

Oct 24, 2024

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast - StockTitan

Oct 24, 2024

Oct 22, 2024

Ainos Inc. secures exclusive patent rights in new deal - Investing.com

Oct 22, 2024

Oct 22, 2024

Ainos Inc. secures exclusive patent rights in new deal By Investing.com - Investing.com UK

Oct 22, 2024

Oct 05, 2024

Ainos (OTCMKTS:AIMD) Stock Price Down 8.7% – Here’s Why - Defense World

Oct 05, 2024

Oct 04, 2024

Ainos Leverages AI Nose for Safer, Smarter Factories - MSN

Oct 04, 2024

Oct 03, 2024

Financial Health Report: Ainos Inc (AIMD)’s Ratios Tell a Tale - The Dwinnex

Oct 03, 2024

Oct 02, 2024

Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges - GuruFocus.com

Oct 02, 2024

Oct 01, 2024

Ainos Inc. secures stockholder nod for special stock awards - Investing.com

Oct 01, 2024

Sep 30, 2024

Ainos planning Phase 3 study of low-dose interferon-alpha for primary Sjögren’s - Sjogren's Syndrome News

Sep 30, 2024

Sep 27, 2024

AIMDWAinos, Inc. Warrants Latest Stock News & Market Updates - StockTitan

Sep 27, 2024

Sep 25, 2024

Ainos Inc (AIMD) Stock: A Year of Highs and Lows - The InvestChronicle

Sep 25, 2024

Sep 25, 2024

Ainos receives IRB nod for HIV-related oral wart trial - Investing.com India

Sep 25, 2024

Sep 25, 2024

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA - StockTitan

Sep 25, 2024

Sep 24, 2024

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome - StockTitan

Sep 24, 2024

Sep 23, 2024

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options - StockTitan

Sep 23, 2024

Sep 20, 2024

Esperion Therapeutics (NASDAQ:ESPR) versus Ainos (NASDAQ:AIMD) Critical Analysis - Defense World

Sep 20, 2024

Sep 20, 2024

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts - StockTitan

Sep 20, 2024

Sep 17, 2024

AIMD stock touches 52-week low at $0.45 amid market challenges - Investing.com

Sep 17, 2024

Sep 17, 2024

Ainos set for clinical trial of HIV treatment at Taiwan hospital - Investing.com

Sep 17, 2024

Sep 17, 2024

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA - StockTitan

Sep 17, 2024

Sep 08, 2024

Financial Review: Ainos (OTCMKTS:AIMD) versus Siemens Healthineers (OTCMKTS:SMMNY) - Defense World

Sep 08, 2024

Sep 06, 2024

Ainos (NASDAQ:AIMD) Shares Down 6.6% - Defense World

Sep 06, 2024

Sep 03, 2024

Ainos secures Taiwan patent for antiviral drug VELDONA - Investing.com

Sep 03, 2024

Sep 03, 2024

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention - Lelezard

Sep 03, 2024

Aug 27, 2024

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Aug 27, 2024

Aug 27, 2024

Ainos (OTCMKTS:AIMD) Stock Price Up 6.1% - Defense World

Aug 27, 2024

Aug 26, 2024

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter - PharmiWeb.com

Aug 26, 2024

Aug 20, 2024

Ainos Inc (AIMD) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Aug 20, 2024

Aug 19, 2024

Is the Ainos Inc (NASDAQ:AIMD) stock an investment opportunity? - US Post News

Aug 19, 2024

Aug 19, 2024

Ainos AI Nose achieves 79% accuracy in VOC detection - Investing.com India

Aug 19, 2024

Aug 19, 2024

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety - AccessWire

Aug 19, 2024